DD201797A5 - Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion - Google Patents

Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion Download PDF

Info

Publication number
DD201797A5
DD201797A5 DD81233310A DD23331081A DD201797A5 DD 201797 A5 DD201797 A5 DD 201797A5 DD 81233310 A DD81233310 A DD 81233310A DD 23331081 A DD23331081 A DD 23331081A DD 201797 A5 DD201797 A5 DD 201797A5
Authority
DD
German Democratic Republic
Prior art keywords
dione
pyrrolizine
dihydro
acid
oxo
Prior art date
Application number
DD81233310A
Other languages
German (de)
English (en)
Inventor
Donald E Butler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DD201797A5 publication Critical patent/DD201797A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DD81233310A 1980-09-15 1981-09-15 Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion DD201797A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18694580A 1980-09-15 1980-09-15
US06/290,114 US4372966A (en) 1980-09-15 1981-08-07 Use of dihydro-1H-pyrrolizine-3,5(2H,6H)-dione as a cognition activator

Publications (1)

Publication Number Publication Date
DD201797A5 true DD201797A5 (de) 1983-08-10

Family

ID=26882585

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81233310A DD201797A5 (de) 1980-09-15 1981-09-15 Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion

Country Status (15)

Country Link
US (1) US4372966A (fr)
EP (1) EP0048132B1 (fr)
AU (1) AU545556B2 (fr)
CA (1) CA1154679A (fr)
DD (1) DD201797A5 (fr)
DE (1) DE3165563D1 (fr)
ES (1) ES505456A0 (fr)
FI (1) FI812853L (fr)
GR (1) GR75026B (fr)
HU (1) HU184883B (fr)
IE (1) IE51514B1 (fr)
IL (1) IL63663A (fr)
NO (1) NO813122L (fr)
NZ (1) NZ198342A (fr)
PH (1) PH18690A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559358A (en) * 1982-05-24 1985-12-17 Warner-Lambert Company 5-Oxo-2-pyrrolidinepropanoic acid and derivatives for reversing electroshock amnesia
US4547519A (en) * 1982-05-24 1985-10-15 Warner-Lambert Company Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acid and benzyl esters and amides thereof and their use in reversing amnesia
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
US4551470A (en) * 1983-08-29 1985-11-05 Warner-Lambert Company Hexahydro-3,5-dioxo-1H-pyrrolizine-2-carboxylic acid and derivatives, and use for reversing electroconvulsive shock amnesia
US4530929A (en) * 1984-02-02 1985-07-23 Warner-Lambert Company Benzotricyclic nitrogen-containing diones and their use in reversing electroconvulsive shock-induced amnesia
US4562195A (en) * 1984-02-02 1985-12-31 Warner-Lambert Company Reversing amnesia with saturated tricyclic nitrogen-containing diones
US4548947A (en) * 1984-05-07 1985-10-22 Warner-Lambert Company 1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia
US4677098A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Substituted dihydro-1H-pyrolizine-3,5(2H,6H)-diones
US4663464A (en) * 1986-03-21 1987-05-05 Warner-Lambert Company Process for the preparation of dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa

Also Published As

Publication number Publication date
HU184883B (en) 1984-10-29
GR75026B (fr) 1984-07-12
CA1154679A (fr) 1983-10-04
US4372966A (en) 1983-02-08
EP0048132B1 (fr) 1984-08-15
IE51514B1 (en) 1987-01-07
EP0048132A2 (fr) 1982-03-24
AU7479981A (en) 1982-03-25
DE3165563D1 (en) 1984-09-20
IE812133L (en) 1982-03-15
EP0048132A3 (en) 1982-05-12
NO813122L (no) 1982-03-16
FI812853L (fi) 1982-03-16
AU545556B2 (en) 1985-07-18
IL63663A (en) 1984-12-31
ES8206526A1 (es) 1982-08-16
PH18690A (en) 1985-09-05
NZ198342A (en) 1984-11-09
IL63663A0 (en) 1981-11-30
ES505456A0 (es) 1982-08-16

Similar Documents

Publication Publication Date Title
DE2147111C3 (de) Verwendung von 3-<4-Biphenylcarbonyl)propionsäure
CH638513A5 (de) Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanonketale.
EP0472501B1 (fr) Sel de codéine et d'un acide carbonique substitué, procédé pour sa préparation, son utilisation et préparations pharmaceutiques
DE2163911B2 (de) 2-Aminomethyl-phenole, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
CH647409A5 (de) Pharmazeutische zubereitung zur behandlung und verhinderung von entzuendlichen darmkrankheiten, salze der 5,5'-azobissalicylsaeure und verfahren zur herstellung dieser salze.
DD201797A5 (de) Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion
DE2403122C2 (fr)
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE2854316A1 (de) Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum
DE2351345A1 (de) Therapeutische zubereitung
DE1932389B2 (de) Neue 2-Naphthyl-2-methyläthanole und deren Acetate, sie enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE2654185C2 (de) N-(p-Benzamido)-2-pyrrolidon-4-carbonsäuren und dieselben enthaltende Anti-Ulcusmittel
DE1964504C3 (de) Arzneimittel zur Behandlung ödematöser Zustände und Hypertensionen
DE2755017C2 (fr)
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE1593765A1 (de) Chelatkomplexverbindung,Verfahren zu ihrer Herstellung,sowie diese Verbindung enthaltende pharmazeutische Praeparate
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE2916880C2 (de) Arzneimittel mit sedativer und schlafinduzierender Wirkung
DE2839311C2 (de) Pharmazeutisches Präparat gegen Geschwüre
DE3706399A1 (de) Mittel mit antidepressiver wirkung
DE1768445C (de) N substituierte beta Oxybutyramid semisuccinate, deren Salze und ihre Her stellung
DE2349971A1 (de) Kristallines pivaloyloxymethyl-d(-)alpha-aminobenzylpenicillinat, verfahren zu seiner herstellung und pharmazeutische mischungen mit einem gehalt an dieser verbindung
DE1645999A1 (de) 1-substituierte 5-Aminotetrazole sowie die Behandlung des tierischen Organismus mit diesen Verbindungen
DE1695379A1 (de) (Dioxo-2,5-pyrolidino-1)-1-(perhydroazepino-1)-4-butin-2 und Verfahren zu seiner Herstellung